A. Shaw

发表

Evidence that high mannose glycopeptides are able to functionally interact with recombinant tumor necrosis factor and recombinant interleukin 1.

P. Wingfield, A. Muchmore, J. Decker, 1990, Cancer research.

Four different interleukin-1 species sensitize to the lethal action of tumour necrosis factor.

W. Fiers, P. Brouckaert, B. Everaerdt, 1989, Biochemical and biophysical research communications.

Effect of endotoxin in IL-1 beta-deficient mice.

G. Fantuzzi, R. Faggioni, P. Ghezzi, 1996, Journal of immunology.

Point mutations of human interleukin‐1 with decreased receptor binding affinity

A. Gronenborn, G. Clore, P. Wingfield, 1986, FEBS letters.

Purification and characterization of human interleukin‐1β expressed in recombinant Escherichia coli

P. Wingfield, J. Tavernier, K. Rose, 1986 .

CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin.

A. Shaw, A. Masellis-Smith, 1994, Journal of immunology.

Preparation, characterization and application of interleukin-1 beta mutant proteins with surface-accessible cysteine residues.

A. Gronenborn, G. Clore, P. Wingfield, 1989, European journal of biochemistry.

Ectopic Expression of Human and Feline CD9 in a Human B Cell Line Confers β1 Integrin-dependent Motility on Fibronectin and Laminin Substrates and Enhanced Tyrosine Phosphorylation (*)

S. Poppema, A. Shaw, L. Fliegel, 1995, The Journal of Biological Chemistry.

A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha.

B. Mach, J. Dayer, A. Shaw, 1987, Journal of immunology.

Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals.

W. Fiers, J. Gugenheim, A. Shaw, 1988, Journal of immunology.

Reduction to benzidine is not necessary for the covalent binding of a benzidine azodye to rat liver DNA.

A. Shaw, C. N. Martin, J. C. Kennelly, 1984, Toxicology.

Purification and characterization of a 26‐kDa competitive inhibitor of interleukin 1

J. Dayer, A. Shaw, G. Mazzei, 1990, European journal of immunology.

Transcripts from the adenovirus-2 major late promoter yield a single early family of 3′ coterminal mRNAs and five late families

A. Shaw, E. Ziff, 1980, Cell.

Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice

C. Libert, W. Fiers, P. Brouckaert, 1990, European journal of immunology.

Human tumor cell membrane glycoprotein associated with protein kinase activity

A. Shaw, B. Longenecker, J. Seehafer, 1984, International journal of cancer.

Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1.

A. Rees, A. Shaw, C. Pusey, 1989, Journal of immunology.

Purification and characterization of human interleukin‐1α produced in Escherichia coli

P. Wingfield, K. Rose, J. Dayer, 1987 .

Changes in relaxin precursor messenger ribonucleic acid levels in ovaries of rats after hysterectomy and removal of conceptuses, and during the estrous cycle.

J. Crish, A. Shaw, M. Soloff, 1986, Endocrinology.

Intrinsic Pituitary Interleukin-1β Is Induced by Bacterial Lipopolysaccharide*

C. Dinarello, J. Cannon, B. D. Clark, 1990 .

Proteoglycan degradation by a chondrocyte metalloprotease. Effects of synthetic protease inhibitors.

A. Shaw, L. Sygowski, C. Caputo, 1987, Biochemical pharmacology.

Modulation of human natural killer cell activity by recombinant human interleukin 2.

P. Barr, A. Shaw, J. Merryweather, 1985, Cellular immunology.

Detection of human IL-1α and IL-1β at the subpicomolar level by colorimetric sandwich enzyme immunoassay

A. Shaw, B. Ferruà, M. Fehlmann, 1988 .

Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor.

W. Fiers, C. Libert, P. Brouckaert, 1991, Journal of immunology.

Isolation and partial characterization of a fragment corresponding to the dimeric form of the CH2 domain of rabbit IgG.

A. Shaw, M. Schlamowitz, W. Mandy, 1986, Molecular immunology.

Improved conditions for the production of monoclonal antibodies to carcinogen-modified DNA, for use in enzyme-linked immunosorbent assays (ELISA).

R. C. Garner, P. Hertzog, A. Shaw, 1983, Journal of immunological methods.

Detection of interleukin 1 alpha and 1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays.

I. Bedrosian, C. Dinarello, F. Cominelli, 1991, Journal of applied physiology.

Detection of interleukin 1α and 1β in rabbit tissues during endotoxemia using sensitive radioimmunoassays

I. Bedrosian, C. Dinarello, F. Cominelli, 1991 .

Localization and characterization of the interleukin 1 immunoreactive pool (IL-1 alpha and beta forms) in normal human epidermis.

J. Saurat, D. Salomon, J. Dayer, 1989, The Journal of investigative dermatology.

The Fc receptor of the fetal rabbit yolk sac membrane.

A. Shaw, M. Schlamowitz, 1983, Methods in enzymology.

Assay and partial characterization of detergent solubilized rabbit yolk sac membrane Fc receptors.

A. Shaw, K. Hillman, M. Schlamowitz, 1980, Journal of immunology.

Covalent disulfide binding of human IL-1β to α2-macroglobulin: Inhibition by d-penicillamine☆

A. Shaw, J. Skosey, M. Teodorescu, 1991 .

Pre-early polypeptides of bacteriophages T5 and BF23

A. Shaw, G. Chinnadurai, D. McCorquodale, 1977, Journal of virology.

Abscisic Acid Structure-Activity Relationships in Barley Aleurone Layers and Protoplasts (Biological Activity of Optically Active, Oxygenated Abscisic Acid Analogs)

A. Shaw, R. Hill, J. -. Liu, 1995, Plant physiology.

Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice.

A. Shaw, Howard Y. Chen, M. Kluger, 1995, Immunity.

The biological activity of 4-chloromethylbiphenyl, benzyl chloride and 4-hydroxymethylbiphenyl in 4 short-term tests for carcinogenicity. A report of an individual study in the UKEMS genotoxicity trial 1981.

R. C. Garner, A. Shaw, S. Booth, 1983, Mutation research.

Interleukin‐1 Beta Gene Deregulation Associated With Chromosomal Rearrangement: A Candidate Initiating Event for Murine Radiation‐Myeloid Leukemogenesis?

R. Cox, A. Shaw, J. Boultwood, 1989, Molecular carcinogenesis.

Net increase of pluripotential hematopoietic precursors in suspension culture in response to IL-1 and IL-3.

A. Shaw, N. Iscove, G. Keller, 1989, Journal of immunology.

Demonstration of relaxin precursors in pregnant rat ovaries with antisera against bacterially expressed rat prorelaxin.

A. Shaw, H. Marquardt, M. Soloff, 1992, Endocrinology.

Terminally redundant deletion mutants of bacteriophage BF23

A. Shaw, D. McCorquodale, D. Lang, 1979, Journal of virology.

Polarized Injection of the Bacteriophage T5 Chromosome

A. Shaw, J. Davison, 1979, Journal of virology.

Is abortive infection by bacteriophage BF23 of Escherichia coli harboring ColIb plasmids due to cell killing by internally liberated colicin Ib?

A. Shaw, E. Moody, D. McCorquodale, 1979, Journal of virology.

Molecular Weights of DNA from Bacteriophages T5, T5st(0), BF23, and BF23st(4)

A. Shaw, D. McCorquodale, D. Lang, 1976, Journal of virology.

Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.

H. Zhang, A. Shaw, M. Letarte, 1996, Journal of immunology.

Immunoreactive interleukin-1β localization in the rat forebrain

C. Dinarello, J. Cannon, B. D. Clark, 1990, Brain Research.

Immunoreactive interleukin-1 beta localization in the rat forebrain.

C. Dinarello, J. Cannon, B. D. Clark, 1990, Brain research.

Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitro.

A. Shaw, C. Caputo, R. Caccese, 1987, The Journal of pharmacology and experimental therapeutics.

Intrinsic pituitary interleukin-1 beta is induced by bacterial lipopolysaccharide.

C. Dinarello, J. Cannon, B. D. Clark, 1990, Endocrinology.

FMC46, a cell protrusion-associated leukocyte adhesion molecule-1 epitope on human lymphocytes and thymocytes.

E. Turley, L. Pilarski, H. Zola, 1991, Journal of immunology.

Functional characterization of promoter elements involved in regulation of human B beta-fibrinogen expression. Evidence for binding of novel activator and repressor proteins.

J. Shafer, A. Shaw, G. Anderson, 1993, The Journal of biological chemistry.

Interleukin 1α acts as an autocrine growth factor for RPMI1788, an Epstein‐Barr virus‐transformed human B cell line

W. Fiers, P. Vandenabeele, R. Devos, 1988 .

Interleukin-1 gene expression in rabbit vascular tissue in vivo.

P. Libby, C. Dinarello, J. Cannon, 1991, The American journal of pathology.

Selective inhibition of adenovirus type 2 early region II and III transcription by an anisomycin block of protein synthesis

A. Shaw, E. Ziff, 1982, Molecular and cellular biology.

Anisomycin Block of Protein Synthesis

A. Shaw, Edward B. ZIFFt, 2022 .

Stimulation of human interleukin 1 production and specific mRNA expression by microtubule-disrupting drugs.

A. Shaw, A. Doglio, S. Manié, 1990, Cellular immunology.

Regulation of Phytochrome B Nuclear Localization through Light-Dependent Unmasking of Nuclear-Localization Signals

J. Chory, Meng Chen, A. Shaw, 2005, Current Biology.

Evidence that the CH2 domain of IgG contains the recognition unit for binding by the fetal rabbit yolk sac membrane receptor.

A. Shaw, R. Johanson, M. Schlamowitz, 1981, Journal of immunology.

Binding, fractionation, and papain susceptibility of groups d and e rabbit IgG allotypes.

A. Shaw, M. Schlamowitz, W. Mandy, 1980, Journal of immunology.

Analysis of mutations in the putative nuclear localization sequence of interleukin-1 beta.

A. Shaw, R. Solari, N. Smithers, 1991, The Biochemical journal.

Activation by PHA of CD8 lymphocytes into clonal colony forming cells. Role of interleukin-1.

F. Reyes, A. Shaw, D. Fradelizi, 1988, Journal of immunological methods.

Changes in relaxin precursor mRNA levels in the rat ovary during pregnancy.

J. Crish, A. Shaw, M. Soloff, 1986, The Journal of biological chemistry.

Cyclooxygenase inhibition enhances rat interleukin 1 beta-induced growth of rat mesangial cells in culture.

F. Thaiss, R. Stahl, A. Shaw, 1990, The American journal of physiology.

Rabbit IL-1. Cloning, expression, biologic properties, and transcription during endotoxemia.

P. Wingfield, C. Dinarello, J. Cannon, 1989, Journal of immunology.

Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.

Y. Zou, D. Pinsky, A. Shaw, 1993, The American journal of pathology.

Bacteria and gallstone nucleation.

L. Vitetta, A. Shaw, A. Sali, 1989, The Australian and New Zealand journal of surgery.

Production of a 26,000-dalton interleukin 1 inhibitor by human monocytes is regulated by granulocyte-macrophage colony-stimulating factor.

A. Shaw, L. Bernasconi, G. Mazzei, 1990, Cytokine.

Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.

M. Kieran, A. Shaw, J. Seehafer, 1982, Journal of the National Cancer Institute.

Characterization of IgC receptors of the fetal rabbit yolk sac membrane: localization to subcellular fraction and effects of chemical agents and enzymes on binding.

A. Shaw, K. Hillman, M. Schlamowitz, 1977, Journal of immunology.

A revaluation of the haemoglobin electrophoretogram of the wistar rat.

A. Shaw, N. Maclean, 1971, Comparative biochemistry and physiology. B, Comparative biochemistry.

Chemical Differences between Antibody Fragments as shown by Paired Label Studies

A. Shaw, D. Pressman, O. Roholt, 1962, Nature.

Interleukin 1 alpha acts as an autocrine growth factor for RPMI 1788, an Epstein-Barr virus-transformed human B cell line.

W. Fiers, P. Vandenabeele, R. Devos, 1988, European journal of immunology.